MedTrace Logo

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

NCT06850623 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-04-03

No results posted yet for this study

Summary

The purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.

Conditions

  • Locally Advanced Pancreatic Adenocarcinoma

Interventions

COMBINATION_PRODUCT

Acoustic Cluster Therapy

Drug: PS101; Device: Ultrasound

DRUG

Modified FOLFIRINOX

Chemotherapy

Sponsors & Collaborators

  • EXACT Therapeutics AS

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-19
Primary Completion
2026-12-15
Completion
2027-07-15
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06850623 on ClinicalTrials.gov